Mice with PAI-1 deficiency, either through gene knockout or the use of a PAI-1 inhibitor, are protected from obesity including hyperglycemia and hyperinsulinemia and demonstrate improved insulin sensitivity [45,46,47,130,131]. Here, SERPINE1 is linked to hyperinsulinism.